Sabin faced significant challenges and competition in developing his vaccine. The scientific community was initially skeptical about using a live virus due to safety concerns. Furthermore, the successful launch of the Salk vaccine created a competitive environment. However, Sabin's persistence and the eventual success of clinical trials proved the efficacy and safety of his vaccine.
